GlassScriptPhysician profile
Charles Lieber
NPI 1588676662
$14,383.83
in general payments reported to CMS, 2019-2025
48 companies · $1,934 in 2025
The $1,934 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,194 · 2020: $1,859 · 2021: $2,291 · 2022: $2,456 · 2023: $2,229 · 2024: $1,420 · 2025: $1,934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,484 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,483.52 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,489.84 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $2,481.05 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,642.01 | 2019-2025 | Ofev, Jardiance, Stiolto Respimat |
| Mylan Specialty L.P. | $628.15 | 2019-2024 | Yupelri |
| Lilly USA, LLC | $486.98 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Regeneron Healthcare Solutions, INC. | $462.72 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $441.64 | 2019-2025 | Prolastin-C Liquid |
| Amarin Pharma, INC. | $418.89 | 2019-2022 | |
| Amgen INC. | $398.29 | 2022-2025 | Tezspire, Evenity, Prolia |
| Genzyme Corporation | $326.73 | 2019-2025 | |
| Novo Nordisk INC | $306.67 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $298.45 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $281.48 | 2019-2024 | Xarelto |
| Mallinckrodt Hospital Products INC. | $248.47 | 2020-2025 | Acthar |
| Sunovion Pharmaceuticals INC. | $241.25 | 2019-2021 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $231.72 | 2020-2024 | Glassia |
| Insmed, INC. | $189.58 | 2022-2025 | Arikayce, Brinsupri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.63 | 2021-2024 | Xifaxan, Trulance |
| Genentech USA, INC. | $144.88 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $134.92 | 2021-2022 | |
| Verona Pharma, INC. | $115.37 | 2025 | Ohtuvayre |
| Abbott Laboratories | $112.59 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Advanced Respiratory, INC | $108.58 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $101.91 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $96.00 | 2019-2025 | Capvaxive, Gardasil 9 |
| Pfizer INC. | $86.55 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $81.77 | 2020-2023 | Nuzyra |
| Biohaven Pharmaceutical Holding Company LTD. | $65.69 | 2022 | |
| Saluda Medical Americas, INC. | $61.30 | 2025 | Evoke |
| Viatris Specialty LLC | $53.63 | 2025 | Yupelri |
| Esperion Therapeutics, INC. | $52.45 | 2023-2024 | Nexletol |
| Irhythm Technologies, INC. | $46.18 | 2024 | Zio Monitor, Zio Xt Patch |
| Baxter Healthcare | $45.58 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Optinose US, INC. | $41.10 | 2020-2025 | |
| United Therapeutics Corporation | $33.00 | 2025 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $28.65 | 2023 | Opsumit |
| 180 Medical, INC. | $27.10 | 2021 | |
| Idorsia Pharmaceuticals US INC | $21.27 | 2022 | |
| Zyla Life Sciences, INC. | $20.67 | 2019 | |
| Medicure Pharma INC. | $20.20 | 2021 | |
| Inspire Medical Systems, INC. | $19.98 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $17.90 | 2020 | |
| Electromed, INC. | $17.82 | 2019 | |
| Mannkind Corporation | $17.71 | 2022 | |
| Circassia INC. | $17.47 | 2019 | |
| Abbvie INC. | $17.28 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.08 | 2025 | Caplyta |
| Cashflow Solutions, LLC | $13.65 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Lieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.